CELCUITY INC. Total Liabilities and Equity
CELCUITY INC. (CELC) had Total Liabilities and Equity of $828.22 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $828.22M.
- 2026-03-31: Liabilities and Equity $410.16M.
- 2025-12-31: Liabilities and Equity $466.56M.
- 2025-09-30: Liabilities and Equity $476.00M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $828.22M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $410.16M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $466.56M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $476.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $183.59M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $218.13M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $245.12M 10-K · filed 2026-03-26 | $245.12M 10-K · filed 2025-03-31 |
| 2024-09-30 | $273.04M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $292.54M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $188.18M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $191.22M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $142.38M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $153.52M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $164.87M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $175.70M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $65.29M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $72.35M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $79.93M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $85.91M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $91.84M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $42.81M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $36.37M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $12.96M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $14.91M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $16.70M 10-Q/A · filed 2020-08-11 | |
| 2020-03-31 | $18.39M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $20.28M 10-K · filed 2021-02-16 | |
| 2019-09-30 | $21.74M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $23.44M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $24.94M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $26.03M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $27.89M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $29.47M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $30.73M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $31.97M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $33.15M 10-Q · filed 2017-12-01 | |
| 2016-12-31 | $6.06M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |